{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:41:33Z","timestamp":1778715693188,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Radiol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00247-021-05226-1","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T08:02:36Z","timestamp":1636444956000},"page":"539-548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Non-inferiority of a non-gadolinium-enhanced magnetic resonance imaging follow-up protocol for isolated optic pathway gliomas"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7614-4399","authenticated-orcid":false,"given":"Ezekiel","family":"Maloney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco A.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh S.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randolph K.","family":"Otto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason N.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah J.","family":"Menashe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2427-4404","authenticated-orcid":false,"given":"Daniel S.","family":"Hippe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis W. W.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Luana","family":"Stanescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,9]]},"reference":[{"key":"5226_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1148\/radiol.2015142690","volume":"276","author":"T Kanda","year":"2015","unstructured":"Kanda T, Fukusato T, Matsuda M et al (2015) Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 276:228\u2013232","journal-title":"Radiology"},{"key":"5226_CR2","doi-asserted-by":"crossref","unstructured":"Miller JH, Hu HH, Pokorney A et al (2015) MRI brain signal intensity changes of a child during the course of 35 gadolinium contrast examinations. Pediatrics 136:e1637\u20131640","DOI":"10.1542\/peds.2015-2222"},{"key":"5226_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00247-017-3810-4","volume":"47","author":"LB Mithal","year":"2017","unstructured":"Mithal LB, Patel PS, Mithal D et al (2017) Use of gadolnium-based magnetic resonance imaging contrast agents and awareness of brain gadolinium deposition among pediatric providers in North America. Pediatr Radiol 47:657\u2013664","journal-title":"Pediatr Radiol"},{"key":"5226_CR4","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.3174\/ajnr.A4891","volume":"37","author":"DR Roberts","year":"2016","unstructured":"Roberts DR, Chatterjee AR, Yazdani M et al (2016) Pediatric patients demonstrate progressive T1-weighted hyperintensity in the dentate nucleus following multiple doses of gadolinium-based contrast agent. AJNR Am J Neuroradiol 37:2340\u20132347","journal-title":"AJNR Am J Neuroradiol"},{"key":"5226_CR5","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1001\/jamapediatrics.2017.0264","volume":"171","author":"JS McDonald","year":"2017","unstructured":"McDonald JS, McDonald RJ, Jentoft ME et al (2017) Intracranial gadolinium deposition following gadodiamide-enhanced magnetic resonance imaging in pediatric patients: a case-control study. JAMA Pediatr 171:705\u2013707","journal-title":"JAMA Pediatr"},{"key":"5226_CR6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s00247-019-04535-w","volume":"50","author":"AL Stanescu","year":"2020","unstructured":"Stanescu AL, Shaw DW, Murata N et al (2020) Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation. Pediatr Radiol 50:388\u2013396","journal-title":"Pediatr Radiol"},{"key":"5226_CR7","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.mri.2016.08.025","volume":"34","author":"N Murata","year":"2016","unstructured":"Murata N, Murata K, Gonzalez-Cuyar LF, Maravilla KR (2016) Gadolinium tissue deposition in brain and bone. Magn Reson Imaging 34:1359\u20131365","journal-title":"Magn Reson Imaging"},{"key":"5226_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/RLI.0000000000000266","volume":"51","author":"DR Roberts","year":"2016","unstructured":"Roberts DR, Lindhorst SM, Welsh CT et al (2016) High levels of gadolinium deposition in the skin of a patient with normal renal function. Invest Radiol 51:280\u2013289","journal-title":"Invest Radiol"},{"key":"5226_CR9","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1148\/radiol.2016152846","volume":"281","author":"N Maximova","year":"2016","unstructured":"Maximova N, Gregori M, Zennaro F et al (2016) Hepatic gadolinium deposition and reversibility after contrast agent-enhanced MR imaging of pediatric hematopoietic stem cell transplant recipients. Radiology 281:418\u2013426","journal-title":"Radiology"},{"key":"5226_CR10","unstructured":"United States Food and Drug Administration (2017) FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body; requires new class warnings. https:\/\/www.fda.gov\/media\/109825\/download. Accessed 11 May 2020"},{"key":"5226_CR11","unstructured":"American College of Radiology (2021) ACR manual on contrast media 2020. https:\/\/www.acr.org\/-\/media\/ACR\/Files\/Clinical-Resources\/Contrast_Media.pdf. Accessed 11 May 2020"},{"key":"5226_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-021-05062-3","author":"SG Harrington","year":"2021","unstructured":"Harrington SG, Jaimes C, Weagle KM et al (2021) Strategies to perform magnetic resonance imaging in infants and young children without sedation. Pediatr Radiol. https:\/\/doi.org\/10.1007\/s00247-021-05062-3","journal-title":"Pediatr Radiol"},{"key":"5226_CR13","first-page":"633","volume-title":"Principles and practice of pediatric oncology","author":"RL Heideman","year":"1993","unstructured":"Heideman RL (1993) Tumors of the central nervous system. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. JB Lippincott, Philadelphia, pp 633\u2013681"},{"key":"5226_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1586\/ern.09.4","volume":"9","author":"AC Albers","year":"2009","unstructured":"Albers AC, Gutmann DH (2009) Gliomas in patients with neurofibromatosis type 1. Expert Rev Neurother 9:535\u2013539","journal-title":"Expert Rev Neurother"},{"key":"5226_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11060-016-2163-4","volume":"129","author":"MJ Wan","year":"2016","unstructured":"Wan MJ, Ullrich NJ, Manley PE et al (2016) Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1. J Neurooncol 129:173\u2013178","journal-title":"J Neurooncol"},{"key":"5226_CR16","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/neuonc\/nos076","volume":"14","author":"MJ Fisher","year":"2012","unstructured":"Fisher MJ, Loguidice M, Gutmann DH et al (2012) Visual outcomes in children with neurofibromatosis type 1 \u2014 associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol 14:790\u2013797","journal-title":"Neuro Oncol"},{"key":"5226_CR17","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1007\/s00247-018-4154-4","volume":"48","author":"E Maloney","year":"2018","unstructured":"Maloney E, Stanescu AL, Perez FA et al (2018) Surveillance magnetic resonance imaging for isolated optic pathway gliomas: is gadolinium necessary? Pediatr Radiol 48:1472\u20131484","journal-title":"Pediatr Radiol"},{"key":"5226_CR18","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00234-020-02609-3","volume":"63","author":"T Campion","year":"2020","unstructured":"Campion T, Quirk B, Cooper J et al (2020) Surveillance imaging of grade 1 astrocytomas in children: can duration and frequency of follow-up imaging and the use of contrast agents be reduced? Neuroradiology 63:953\u2013958","journal-title":"Neuroradiology"},{"key":"5226_CR19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00234-019-02198-w","volume":"61","author":"P Marsault","year":"2019","unstructured":"Marsault P, Ducassou S, Menut F et al (2019) Diagnostic performance of an unenhanced MRI exam for tumor follow-up of the optic pathway gliomas in children. Neuroradiology 61:711\u2013720","journal-title":"Neuroradiology"},{"key":"5226_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11060-010-0159-z","volume":"100","author":"P Hernaiz Driever","year":"2010","unstructured":"Hernaiz Driever P, von Hornstein S, Pietsch T et al (2010) Natural history and management of low-grade glioma in NF-1 children. J Neurooncol 100:199\u2013207","journal-title":"J Neurooncol"},{"key":"5226_CR21","first-page":"1963","volume":"22","author":"L Kornreich","year":"2001","unstructured":"Kornreich L, Blaser S, Schwarz M et al (2001) Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis. AJNR Am J Neuroradiol 22:1963\u20131969","journal-title":"AJNR Am J Neuroradiol"},{"key":"5226_CR22","first-page":"1823","volume-title":"Walsh & Hoyt's clinical neuro-ophthalmology","author":"JB Kerrison","year":"2005","unstructured":"Kerrison JB (2005) Chapter 38: phacomatoses. In: Miller NR (ed) Walsh & Hoyt\u2019s clinical neuro-ophthalmology, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1823\u20131898","edition":"6"},{"key":"5226_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1259\/bjr.74.877.740024","volume":"74","author":"JF Chateil","year":"2001","unstructured":"Chateil JF, Soussotte C, Pedespan JM et al (2001) MRI and clinical differences between optic pathway tumours in children with and without neurofibromatosis. Br J Radiol 74:24\u201331","journal-title":"Br J Radiol"},{"key":"5226_CR24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1259\/bjr\/65246351","volume":"81","author":"T Taylor","year":"2008","unstructured":"Taylor T, Jaspan T, Milano G et al (2008) Radiological classification of optic pathway gliomas: experience of a modified functional classification system. Br J Radiol 81:761\u2013766","journal-title":"Br J Radiol"},{"key":"5226_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.acra.2008.05.014","volume":"16","author":"NA Obuchowski","year":"2009","unstructured":"Obuchowski NA (2009) Reducing the number of reader interpretations in MRMC studies. Acad Radiol 16:209\u2013217","journal-title":"Acad Radiol"},{"key":"5226_CR26","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1200\/JCO.2011.36.6054","volume":"30","author":"JL Ater","year":"2012","unstructured":"Ater JL, Zhou T, Holmes E et al (2012) Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children\u2019s Oncology Group. J Clin Oncol 30:2641\u20132647","journal-title":"J Clin Oncol"},{"key":"5226_CR27","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.ophtha.2011.12.035","volume":"119","author":"JP Kelly","year":"2012","unstructured":"Kelly JP, Leary S, Khanna P, Weiss AH (2012) Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas. Ophthalmology 119:1231\u20131237","journal-title":"Ophthalmology"},{"key":"5226_CR28","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/pbc.25480","volume":"62","author":"B Shofty","year":"2015","unstructured":"Shofty B, Mauda-Havakuk M, Weizman L et al (2015) The effect of chemotherapy on optic pathway gliomas and their sub-components: a volumetric MR analysis study. Pediatr Blood Cancer 62:1353\u20131359","journal-title":"Pediatr Blood Cancer"},{"key":"5226_CR29","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1470-2045(11)70057-2","volume":"12","author":"MJ van den Bent","year":"2011","unstructured":"van den Bent MJ, Wefel JS, Schiff D et al (2011) Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 12:583\u2013593","journal-title":"Lancet Oncol"},{"key":"5226_CR30","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1200\/JCO.2017.72.7511","volume":"35","author":"PY Wen","year":"2017","unstructured":"Wen PY, Chang SM, Van den Bent MJ et al (2017) Response assessment in neuro-oncology clinical trials. J Clin Oncol 35:2439\u20132449","journal-title":"J Clin Oncol"},{"key":"5226_CR31","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1016\/S1470-2045(20)30064-4","volume":"21","author":"J Fangusaro","year":"2020","unstructured":"Fangusaro J, Witt O, Hernaiz Driever P et al (2020) Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol 21:e305\u2013e316","journal-title":"Lancet Oncol"},{"key":"5226_CR32","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1148\/radiol.2252011604","volume":"225","author":"SR Prasad","year":"2002","unstructured":"Prasad SR, Jhaveri KS, Saini S et al (2002) CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology 225:416\u2013419","journal-title":"Radiology"},{"key":"5226_CR33","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1259\/bjr.73.875.11144795","volume":"73","author":"SA Sohaib","year":"2000","unstructured":"Sohaib SA, Turner B, Hanson JA et al (2000) CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size. Br J Radiol 73:1178\u20131184","journal-title":"Br J Radiol"},{"key":"5226_CR34","unstructured":"R Core Team (2016). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. https:\/\/www.R-project.org\/. Accessed 25 Sep 2021"},{"key":"5226_CR35","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med 22:276\u2013282","journal-title":"Biochem Med"}],"container-title":["Pediatric Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-021-05226-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00247-021-05226-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-021-05226-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T00:27:24Z","timestamp":1645230444000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00247-021-05226-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,9]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["5226"],"URL":"https:\/\/doi.org\/10.1007\/s00247-021-05226-1","relation":{},"ISSN":["0301-0449","1432-1998"],"issn-type":[{"value":"0301-0449","type":"print"},{"value":"1432-1998","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,9]]},"assertion":[{"value":"5 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}